- DBV Technologies (DBVT, Financial) reports a total of 136,948,872 shares outstanding as of April 30, 2025.
- The company disclosed gross voting rights of 136,948,872 and net voting rights of 136,762,549.
- Disclosure complies with French financial regulations under AMF's Article 223-16.
DBV Technologies (DBVT), a leading player in the biotechnology sector, has released its monthly disclosure of voting rights for April 30, 2025. The company reported a total of 136,948,872 shares outstanding, which equates to the same number of gross voting rights.
The net voting rights, which account for shares without voting rights, are reported at 136,762,549. This indicates a difference of 186,323 voting rights between the gross and net figures.
This disclosure is a regulatory requirement under Article 223-16 of the General Regulations of the Autorité des Marchés Financiers (AMF) for companies listed on NYSE Euronext Paris. DBV Technologies continues to ensure transparency and compliance in its financial reporting practices.